Close

Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $59.45 (+23.1%) * Over Last 12-Mos
Rating Score: 1.7 / 10   Percentile Rank: 12%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/11/2024 Societe Generale Justin Smith Downgrade Hold
(Buy)
51.00
(85.00)
53.79
(48.28)
-10.24% Details
2/6/2024 Redburn-Atlantic Steve Chesney Downgrade Neutral
(Buy)
54.00
(77.00)
48.71
(48.28)
-0.88% Details
Like BMY Ratings? Also take a look at RYZB, TSVT, KRTX, ABBV

BMY Ratings News